Skip to main content

The biotechs that top Deloitte’s Fast 500 Tech: Boston Heart Diagnostics, Novavax and more

By November 20, 2014News
deloitte-biotech-fast-100-medcity-chart

deloitte-biotech-fast-100-medcity-chart

Deloitte recently released its 2014 Technology Fast 500 Rankings, and biotech companies ranked third-quickest in growth following software and internet firms. The biotech industry, over all, grew 940 percent this year – the lowest it’s been, actually, in the past decade. Last year, for instance, the it grew 2,723 percent, in 2012 it was 3,734 – the lowest since this year was in 2005, when growth was at 1,420 percent.

{iframe}http://medcitynews.com/2014/11/the-biotechs-that-top-deloitte-fast-500-boston-heart-diagnostics-novavax-and-more/{/iframe}

Leave a Reply

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.